Prescription Drugs
Absent any statutory consequences for not completing the OPPS Drug Acquisition Cost Survey (ODACS), it is wrong for CMS to tell hospitals and health systems that they “are to” complete it.
The Department of Health and Human Services and Drug Enforcement Administration Dec. 30 released a temporary rule extending for the fourth time waiver flexibilities for prescribing controlled substances via telemedicine.
The Department of Health and Human Services (HHS) and Drug Enforcement Administration (DEA) Dec. 30 released a temporary rule extending for the fourth time waiver flexibilities for prescribing controlled substances via telemedicine.
The Centers for Medicare & Medicaid Services (CMS) Nov. 28 released its proposed Policy and Technical Changes to the Medicare Advantage (MA) Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program and Programs of All-Inclusive Care for the Elderly for Contract Year (CY)…
In February, the American Hospital Association, The Pew Charitable Trusts and the American Society of Health-System Pharmacists convened organizations representing pharmacists, doctors, hospitals and health care systems, the U.S. Centers for Disease Control, State boards of pharmacy and the U.S.…
We applaud final Senate passage of the reauthorization of the Food and Drug Administration Safety and Innovation Act.
We applaud final House passage of the reauthorization of the Food and Drug Administration Safety and Innovation Act.
We applaud Congressional passage of the reauthorization of the Prescription Drug User Fee Act. The number of drug shortages has tripled in the last six years and the shortages have affected patient care.